This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
We review the 2024 average FICO score, what it implies for loan pricing, and practical steps to improve beyond the average.
8,903 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
This article breaks down a hypothetical Q4 2025 earnings transcript for W&T Offshore, focusing on how offshore (wti) ...
In a bid to curb pump prices, the Trump administration announced a temporary waiver of the Jones Act. Early market re...
Ethereum slid about 5% to $2,100 amid a broader market pullback, but on-chain metrics point to a possible long-term b...
A disciplined investor asks: can a modest, cash-backed bet on a distressed stock generate alpha? This article breaks ...
Monero's XMR remains in a tight range around the mid-$180s as liquidity thins. Analysts say the trapped setup could f...
When a director sells shares after a sharp gain, it can spark questions about the stock’s future. This article breaks...
When a company director sells a large block of stock, it can raise questions. This guide explains what signals to wat...
Netflix unveiled a broad price increase across every U.S. tier, with an 11% average lift. JPMorgan says the move coul...
Bitcoin, XRP, Ethereum, and Solana have all declined 6-8% over the past week, dragging the crypto market lower amid E...
A strong first quarter and solid cash generation helped CVS Health's shares spark on Wednesday. This guide breaks dow...
A focused look at Toast's Q1 2026 results and what they imply for toast (tost) 2026 earnings. Expect discussion of re...